HCM
AERI

Harvey Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

Harvey Capital Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-22,400
Closed -$661K – 81
2019
Q2 		$661K Buy
+22,400
New +$863K 0.32% 52
2018
Q3 		– Sell
-7,525
Closed -$508K – 77
2018
Q2 		$508K Sell
7,525
-15,994
-68% -$895K 0.2% 62
2018
Q1 		$1.27M Hold
23,519
– – 0.48% 52
2017
Q4 		$1.41M Sell
23,519
-1,281
-5% -$77.7K 0.51% 47
2017
Q3 		$1.21M Sell
24,800
-1,900
-7% -$104K 0.49% 43
2017
Q2 		$1.4M Sell
26,700
-30,400
-53% -$1.42M 0.6% 41
2017
Q1 		$2.59M Sell
57,100
-12,425
-18% -$554K 1.16% 28
2016
Q4 		$2.63M Sell
69,525
-4,450
-6% -$168K 1.23% 28
2016
Q3 		$2.79M Sell
73,975
-35,075
-32% -$773K 0.86% 26
2016
Q2 		$1.92M Sell
109,050
-3,450
-3% -$55.9K 0.96% 30
2016
Q1 		$1.37M Sell
112,500
-5,950
-5% -$94.1K 0.66% 35
2015
Q4 		$2.88M Sell
118,450
-3,400
-3% -$79.3K 1.14% 33
2015
Q3 		$2.16M Sell
121,850
-101,350
-45% -$1.84M 0.86% 33
2015
Q2 		$3.86M Buy
223,200
+75,800
+51% +$1.39M 1.3% 25
2015
Q1 		$4.62M Buy
147,400
+12,000
+9% +$348K 1.7% 21
2014
Q4 		$3.95M Sell
135,400
-1,000
-0.7% -$25.4K 1.52% 21
2014
Q3 		$2.82M Buy
+136,400
New +$2.69M 1.11% 26

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Harvey Capital Management's AERI Position: Q3 2019 in Review

Harvey Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q3 2019, closing a stake of 22,400 shares — an estimated $661K sold.

Harvey Capital Management first reported a position in AERI in Q3 2014 and held it in 17 quarters. The position peaked at $4.62M in Q1 2015. 167 funds tracked by Wall St. Rank hold AERI as of Q3 2019.

  • Harvey Capital Management reported no remaining Aerie Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Harvey Capital Management sold 22,400 Aerie Pharmaceuticals shares in Q3 2019, an estimated $661K.
  • Harvey Capital Management first reported a position in Aerie Pharmaceuticals in Q3 2014 and held it in 17 quarters.
  • Harvey Capital Management's Aerie Pharmaceuticals position peaked at $4.62M in Q1 2015.
  • 167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2019.

Based on Harvey Capital Management's 13F filing for Q3 2019, filed 17 Oct 2019.